Department of Health Convergence, Ewha Womans University, Seoul, Republic of Korea.
Department of Health Convergence, Graduate School of Industrial Pharmaceutical Science, Ewha Womans University, Seoul, Republic of Korea.
Pharmacoepidemiol Drug Saf. 2024 Sep;33(9):e70006. doi: 10.1002/pds.70006.
Several cases of renal complications, including acute kidney injury (AKI), after influenza vaccination have been reported, but the association remains unproven. We evaluated the association between influenza vaccination and AKI occurrence among the Korean elderly in the 2018-2019 and 2019-2020 seasons.
We used a large database combining vaccination registration data from the Korea Disease Control and Prevention Agency and claims data from the National Health Insurance Service. The study subjects were patients hospitalized with AKI for the first-time following vaccination among those who received one influenza vaccine in the 2018-2019 or 2019-2020 season. Only those aged 65 or older at the date of vaccination were included. We performed a self-controlled case series study, designating the risk period as 1 to 28 days post-vaccination and the observation period as each influenza season. The adjusted incidence rate ratio (aIRR) was calculated by adjusting for nephrotoxic drug use and influenza infection that may influence AKI occurrence using a conditional Poisson regression model.
A total of 16 713 and 16 272 AKI events were identified during the 2018-2019 and 2019-2020 seasons, respectively. The aIRR for AKI was 0.83 (95% confidence interval [CI] = 0.79-0.87) in the 2018-2019 season. The aIRR for the 2019-2020 influenza season was similar to the 2018-2019 season (aIRR = 0.86; 95% CI = 0.82-0.90).
Influenza vaccination is associated with a lower risk of AKI in the elderly over 65. This evidence supports the recommendation of annual influenza vaccination for the elderly. Further studies are needed to determine the biological mechanisms linking the influenza vaccine and AKI.
有报道称,流感疫苗接种后会出现几种肾脏并发症,包括急性肾损伤(AKI),但两者之间的关联尚未得到证实。我们评估了 2018-2019 年和 2019-2020 年期间韩国老年人接种流感疫苗与 AKI 发生之间的关联。
我们使用了一个大型数据库,该数据库结合了韩国疾病控制与预防署的疫苗接种登记数据和国家健康保险服务的理赔数据。研究对象为 2018-2019 年或 2019-2020 年期间首次接种流感疫苗后因 AKI 住院的患者。仅纳入接种疫苗时年龄在 65 岁及以上的患者。我们进行了自身对照病例系列研究,将风险期定义为接种后 1-28 天,观察期为每个流感季节。使用条件泊松回归模型,通过调整可能影响 AKI 发生的肾毒性药物使用和流感感染情况,计算调整后的发病率比(aIRR)。
在 2018-2019 年和 2019-2020 年期间,分别确定了 16713 例和 16272 例 AKI 事件。在 2018-2019 年季节中,AKI 的 aIRR 为 0.83(95%置信区间 [CI] = 0.79-0.87)。2019-2020 流感季节的 aIRR 与 2018-2019 季节相似(aIRR=0.86;95%CI=0.82-0.90)。
流感疫苗接种与 65 岁以上老年人 AKI 的风险降低相关。这一证据支持为老年人推荐每年接种流感疫苗。需要进一步的研究来确定流感疫苗和 AKI 之间的生物学机制。